期刊文献+

VEGF-D的表达与膀胱移行细胞癌LVD及淋巴结转移有关 被引量:2

VEGF-D EXPRESSION IS RELATED WITH LVD AND LYMPH NODE METASTASIS IN BLADDER TRANSITIONAL CELL CARCINOMA
下载PDF
导出
摘要 目的观察血管内皮生长因子D(vascular endothelial growth factor D,VEGF-D)在人膀胱移行细胞癌组织内的表达,探讨VEGF-D在膀胱移行细胞癌组织淋巴管密度(lymphatic vessel density,LVD)及淋巴结转移之间的关系。方法取人膀胱移行细胞癌组织蜡块30例,免疫组化法观察VEGF-D在膀胱移行细胞癌组织内的表达情况。以淋巴管内皮特异性标记物D2-40标记淋巴管,计数癌组织内淋巴管密度。结果VEGF-D蛋白主要表达于癌细胞胞浆内,VEGF-D在淋巴结转移组膀胱移行细胞癌组织内的表达水平明显高于无淋巴结转移组(P<0.05);淋巴结转移组膀胱移行细胞癌组织内的淋巴管密度明显高于无淋巴结转移组(P<0.05)。VEGF-D表达与膀胱移行细胞癌淋巴管密度及淋巴结转移之间具有显著的相关性。结论VEGF-D表达在膀胱移行细胞癌组织内淋巴管生成及淋巴结转移中起重要作用。 Objective To investigate the relationship between VEGF-D (vascular endothelial growth factor D) and lymphatic vessel density (LVD) as well as lymph node metastasis in human bladder transitional cell carcinoma.Methods The expression of VEGF-D protein was examined in 30 cases of transitional cell carcinoma of the bladder by immunohistochemistry. D2-40 was used to detect lymphatic vessels as the specific marker of lymphatic endothelium. Results VEGF-D protein was detected in the cytoplasm of malignant cells. VEGF-D expression and LVD in the lymph node metastatic group was significantly higher than those in the nonmetastatic group (P〈0.05). VEGF-D expression was closely related with the tumor LVD and lymph node metastasis. Conclusion VEGF-D plays an important role in lymphangiogenesis and lymph node metastasis of bladder transitional cell carcinoma.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2010年第1期81-84,共4页 Chinese Journal of Histochemistry and Cytochemistry
基金 黑龙江省自然科学基金资助项目(2005-04)
关键词 血管内皮生长因子-D 淋巴管生成 膀胱移行细胞癌 D2-40 VEGF(Vascular endothelial growth factor)-D Lymphangiogenesis Bladder transitional cell carcinoma D2-40
  • 相关文献

参考文献9

  • 1Renyi-Vamos F,Tovari J,Fillinger J,et al.Lymphangiogenesis correlates with lymph node metastasis,prognosis and angiogenic phenotype in human non-small cell lung cancer.Clin Cancer Res,2005,11(20):7344-7353.
  • 2Dadras SS,Lange-Asschenfeldt B,Velasco P,et al.Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.Mod Pathol,2005,18(9):1232-1242.
  • 3Fukunaga M.Expression of D2-40 in lymphatic endothelium.Histopathology,2005,46(4):396-402.
  • 4Suzuki K,Morita T,Tokue A.Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.Int J Urol,2005,12(2):152-158.
  • 5Miyata Y,Kanda S,Ohba K,et al.Lymphangiogenesis and angiogenesis in bladder cancer:prognostic implications and regulation by vascular endothelial growth factors-A,-C,and -D.Clin Cancer Res,2006,12(3):800-806.
  • 6Stacker SA,Caesar C,Baldwin ME,et al.VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.Nat Med,2001,7(2):186-191.
  • 7Shintani S,Li C,Ishikawa T,et al.Expression of vascularendothelial growth factor A,B,C,and D in oral squamous cell carcinoma.Oral Oncol,2004,40(1):13-20.
  • 8Stearns ME,Wang M,Hu Y,et al.Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors.VEGF D and flt-4t (Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis.Lab Inves,2004,84(6):785-795.
  • 9Currie MJ,Hanrahan V,Gunningham SP,et al.Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1,but not lymph node metastasis in primary human breast carcinomas.J Clin Pathol,2004,57(8):829-834.

同被引文献19

  • 1Ying Zhang,Thomas Musci,Rik Derynck.The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function[J].Current Biology.1997(4)
  • 2Chen Chen,Sun Ming-Zhong,Liu Shuqing,Yeh Dongmei,Yu Lijun,Song Yang,Gong Linlin,Hao Lihong,Hu Jun,Shao Shujuan.Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF[].BMB reports.2010
  • 3Skobe M,Hawighorst T,Jackson DG,et al.Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[].Nature Medicine.2001
  • 4Schwart_Waldhoff I,VolpertOV,BouckNP. et al.Smad4/DPC4_mediated tumor suppression through suppression of angiogenesis[].Proceedings of the National Academy of Sciences of the United States of America.2000
  • 5Deguchi Katsuya,Ichikawa Daisuke,Soga Koji,Watanabe Kenji,Kosuga Toshiyuki,Takeshita Hiroki,Konishi Hirotaka,Morimura Ryo,Tsujiura Masahiro,Komatsu Shuhei,Shiozaki Atsushi,Okamoto Kazuma,Fujiwara Hitoshi,Otsuji Eigo.Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer[].Anticancer Research.2010
  • 6Mitsunobu R. Kano,Younsoo Bae,Caname Iwata,Yasuyuki Morishita,Masakazu Yashiro,Masako Oka,Tomoko Fujii,Akiyoshi Komuro,Kunihiko Kiyono,Michio Kaminishi,Kosei Hirakawa,Yasuyoshi Ouchi,Nobuhiro Nishiyama,Kazunori Kataoka,Kohei Miyazono.Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling[].Proceedings of the National Academy of Sciences of the United States of America.2007
  • 7Bierie Brian,Moses Harold L.Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer[].Nature reviews Cancer.2006
  • 8Nathanson SD.Insights into the mechanisms of lymph node metastasis[].Cancer.2003
  • 9Liffers Sven-T,Maghnouj Abdelouahid,Munding Johanna B,Jackstadt René,Herbrand Ulrike,Schulenborg Thomas,Marcus Katrin,Klein-Scory Susanne,Schmiegel Wolff,Schwarte-Waldhoff Irmgard,Meyer Helmut E,Stühler Kai,Hahn Stephan A.Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε[].BMC Cancer.2011
  • 10Vlad G, Chang CC, Colovai AI, et al. Immunoglobulin-like tran- script 3:A crucial regulator of dendritic cell function [ J ]. Hum Immunol, 2009, 70:340-344.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部